Responses
Clinical and epidemiological research
Extended report
Adalimumab in patients with hand osteoarthritis refractory to analgesics and NSAIDs: a randomised, multicentre, double-blind, placebo-controlled trial
Compose a Response to This Article
Other responses
No responses have been published for this article.